Plasma adrenomedullin levels during multiple pregnancy

Gynecologic and Obstetric Investigation

Volumn 69, Issue 3, 2010, Pages 169-173

  Shinozaki, Hiromitsu ^a   Aoki, Hiroshi ^a   Kasahara, Yoshimitsu ^a   Kangawa, Kenji ^b   Minegishi, Takashi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adrenomedullin; Multiple pregnancy

Indexed keywords

ADRENOMEDULLIN;

ARTERIAL BLOOD; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MULTIPLE PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TWIN PREGNANCY; VENOUS BLOOD;

ADRENOMEDULLIN; FEMALE; HUMANS; PLACENTAL CIRCULATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PREGNANCY, MULTIPLE; RADIOIMMUNOASSAY; REFERENCE VALUES; REGIONAL BLOOD FLOW; UTERUS;

EID: 72049092712     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265526     Document Type: Article

References (14)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560. (Pubitemid 23227359)
2. Walters WAW, Lim YL: Blood volume and haemodynamics in pregnancy. Clin Obstet Gynecol 1975; 2: 301-320.
3. Di Iorio R, Marinoni E, Scavo D, Letizia C, Cosmi EV: Adrenomedullin in pregnancy. Lancet 1997; 349: 328.
4. Kitamura K, Kato J, Kawamoto M, Tanaka M, Chino N, Kangawa K, Eto T: The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun 1998; 244: 551-555.
5. Kitamura K, Ichiki Y, Tanaka M, Kawamoto M, Emura J, Sakakibara S, Kangawa K, Matsuo H, Eto T: Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341: 288-290.
6. Hata T, Miyazaki K, Matsui K: Decreased circulating adrenomedullin in pre-eclampsia. Lancet 1997; 350: 1600.
7. Di Iorio R, Marinoni E, Letizia C, Alo P, Villaccio B, Cosmi EV: Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia. Hypertension 1998; 32: 758-763.
8. Eguchi S, Hirata Y, Iwasaki H, Sato K, Watanabe TX, Inui T, Nakajima K, Sakakibara S, Marumo F: Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 1994; 135: 2454-2458.
9. Minegishi T, Nakamura M, Abe K, Tano M, Andoh A, Yoshida M, Takagi T, Nishikimi T, Kojima M, Kangawa K: Adrenomedullin and atrial natriuretic peptide concentrations in normal pregnancy and pre-eclampsia. Mol Hum Reprod 1999; 5: 767-770.
10. Li M, Yee D, Magnuson TR, Smithies O, Caron KM: Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest 2006; 116: 2653-2662.
11. Li M, Wu Y, Caron KM: Haploinsufficiency for adrenomedullin reduces pinopodes and diminishes uterine receptivity in mice. Biol Reprod 2008; 79: 1169-1175.
12. Penchalaneni J, Wimalawansa SJ, Yallampalli C: Adrenomedullin antagonist treatment during early gestation in rats causes fetoplacental growth restriction through apoptosis. Biol Reprod 2004; 71: 1475-1483.
13. Witlin AG, Li ZY, Wimalawansa SJ, Grady JJ, Grafe MR, Yallampalli C: Placental and fetal growth and development in late rat gestation is dependent on adrenomedullin. Biol Reprod 2002; 67: 1025-1031.
14. Marinoni E, Di Iorio R, Letizia C, Villaccio B, Scucchi L, Cosmi EV: Immunoreactive adrenomedullin in human fetoplacental tissues. Am J Obstet Gynecol 1998; 179: 784-787.